3860 — EPS Creative Health Technology Balance Sheet
0.000.00%
- HK$349.46m
- HK$274.21m
- HK$457.65m
Annual balance sheet for EPS Creative Health Technology, fiscal year end - March 31st, HKD millions except per share, conversion factor applied.
R2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 208 | 131 | 116 | 136 | 127 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 30.5 | 42.3 | 71.6 | 75.4 | 54.3 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 285 | 217 | 212 | 232 | 212 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 7.29 | 6.05 | 9.65 | 9.08 | 8.54 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 297 | 227 | 430 | 337 | 311 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 82.3 | 115 | 205 | 80.2 | 116 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 165 | 140 | 365 | 216 | 205 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 131 | 87.6 | 65.4 | 121 | 106 |
| Total Liabilities & Shareholders' Equity | 297 | 227 | 430 | 337 | 311 |
| Total Common Shares Outstanding |